Complete Filing Data
Kayne Anderson BDC, Inc. reported Stockholders Equity of $1.11 billion for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Kayne Anderson BDC, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Net Income * | $93.7M | $131.9M | $77.1M | $45.8M | $22.3M |
| Other General And Administrative Expense | $2.4M | $2.2M | $1.6M | $1.4M | $677.0K |
| Operating Expenses | $120.3M | $101.6M | $76.2M | $34.7M | $8.6M |
| Investment Income Nonoperating | $235.8M | $213.1M | $161.0M | $74.8M | $18.8M |
| Income Loss From Continuing Operations Per Diluted Share | $1.33 | $2.07 | $1.96 | $1.68 | $2.08 |
| Income Loss From Continuing Operations Per Basic Share | $1.33 | $2.07 | $1.96 | $1.68 | $2.08 |
| Operating Income Loss | -$118.2M | -$83.8M | -$76.2M | -$34.7M | |
| Interest Expense Operating | $76.4M | $61.5M | $52.3M | $20.3M | |
| Interest Expense | $52.3M | $20.3M | $4.5M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | $24.6M | $24.9M | $22.2M | $37.6M | $31.2M | $27.8M | $13.9M | $21.0M | $19.4M | $5.7M | |||
| Other General And Administrative Expense | $591.0K | $603.0K | $581.0K | $563.0K | $508.0K | $471.0K | $345.0K | $422.0K | $449.0K | $345.0K | $302.0K | $314.0K | $201.0K |
| Operating Expenses | $31.3M | $29.4M | $27.8M | $27.6M | $22.6M | $22.7M | $19.8M | $19.0M | $17.1M | $9.3M | $5.9M | $5.7M | $2.0M |
| Investment Income Nonoperating | $61.4M | $57.3M | $55.2M | $57.8M | $52.5M | $46.5M | $41.2M | $40.7M | $36.4M | $20.5M | $13.0M | $11.9M | $5.0M |
| Income Loss From Continuing Operations Per Diluted Share | $0.35 | $0.35 | $0.31 | $0.53 | $0.46 | $0.61 | $0.34 | $0.54 | $0.54 | $0.49 | $0.32 | $0.26 | $0.36 |
| Income Loss From Continuing Operations Per Basic Share | $0.35 | $0.35 | $0.31 | $0.53 | $0.46 | $0.61 | $0.34 | $0.54 | $0.54 | $0.49 | $0.32 | $0.26 | $0.36 |
| Operating Income Loss | -$31.3M | -$28.6M | -$26.5M | -$20.8M | -$18.1M | -$22.7M | -$19.8M | -$19.0M | |||||
| Interest Expense Operating | $20.2M | $18.4M | $17.1M | $16.1M | $13.2M | $15.7M | $13.9M | $13.0M | |||||
| Interest Expense | $15.7M | $13.9M | $13.0M | $11.5M | $5.5M | $3.0M | $2.8M | $948.0K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Stockholders Equity | $1.11B | $1.19B | $683.1M | $592.0M | $312.0M | -$798.0K |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $18.0M | $22.4M | $34.1M | $8.5M | $2.0M | $10.0K |
| Unrealized Gain Loss On Investments | -$22.2M | $2.8M | $2.9M | $5.5M | $11.8M | |
| Net Decrease In Net Assets Resulting From Stockholder Distributions | -$126.2M | -$111.9M | -$81.6M | -$39.6M | -$10.5M | |
| Stockholders Equity Period Increase Decrease | -$76.4M | $503.3M | $91.0M | $280.1M | $312.8M | |
| Purchases Of Portfolio Investments | $773.8M | $983.5M | $391.3M | $718.2M | $647.5M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -$4.3M | -$11.7M | $25.5M | $6.5M | $2.0M | |
| Accretion Amortization Of Discounts And Premiums Investments | $15.3M | $12.5M | $9.8M | $4.8M | $1.2M | |
| Retained Earnings Accumulated Deficit | $1.9M | $33.9M | $13.0M | $17.5M | $11.2M | |
| Prepaid Expense And Other Assets | $291.0K | $958.0K | $319.0K | $347.0K | $148.0K | |
| Management Fee Payable | $5.6M | $3.7M | $3.0M | $2.4M | $952.0K | |
| Liabilities And Stockholders Equity | $2.29B | $2.08B | $1.42B | $1.19B | $586.5M | |
| Liabilities | $1.18B | $896.3M | $740.6M | $602.4M | $274.5M | |
| Interest Receivable | $24.1M | $15.0M | $12.9M | $10.4M | $2.1M | |
| Common Stock Value | $68.0K | $71.0K | $42.0K | $36.0K | $19.0K | |
| Assets | $2.29B | $2.08B | $1.42B | $1.19B | $586.5M | |
| Accrued Liabilities And Other Liabilities | $22.0M | $15.2M | $11.9M | $7.2M | $2.5M | |
| Paidinkind Interest From Portfolio Investments | $9.1M | $2.7M | $1.7M | $151.0K | $173.0K | |
| Increasedecrease In Receivable For Principal Payments On Investments | -$232.0K | $436.0K | -$7.0K | $111.0K | ||
| Receivable For Principal Payments On Investments | $308.0K | $540.0K | $104.0K | $111.0K | ||
| Net Increase In Net Assets Resulting From Capital Share Transactions | $95.6M | $273.9M | $301.0M | |||
| Net Change In Unrealized Gains Losses Investments | $2.9M | $5.5M | $11.8M | |||
| Distribution Payable | $27.2M | $28.4M | $22.1M | $15.4M | ||
| Shortterm Investmentsamortized Cost | $48.7M | $12.8M | $9.8M | $3.7M | ||
| Short Term Investments | $48.7M | $12.8M | $9.8M | $3.7M | ||
| Gain Loss On Investments | -$22.2M | $3.4M | -$7.7M | $5.6M | ||
| Cash And Cash Equivalents At Carrying Value | $22.4M | $34.1M | $8.5M | $2.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $1.14B | $1.16B | $1.18B | $1.19B | $1.18B | $811.6M | $680.7M | $646.9M | $595.5M | $523.7M | $389.8M | $387.2M | $192.7M | $145.0M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $16.4M | $14.0M | $17.4M | $39.1M | $20.3M | $33.4M | $12.4M | $12.9M | $11.2M | $15.3M | $3.4M | $5.8M | $1.2M | |
| Unrealized Gain Loss On Investments | -$5.0M | -$3.5M | -$6.5M | $503.0K | -$3.1M | $4.0M | -$7.5M | -$731.0K | $125.0K | $3.3M | $322.0K | -$512.0K | $989.0K | |
| Net Decrease In Net Assets Resulting From Stockholder Distributions | -$27.9M | -$35.4M | -$35.6M | -$28.4M | -$28.4M | -$19.5M | -$22.0M | -$20.7M | -$16.9M | -$7.1M | -$6.1M | -$2.0M | ||
| Stockholders Equity Period Increase Decrease | -$17.2M | -$19.2M | -$9.8M | $8.0M | $366.6M | $128.5M | $33.8M | $51.4M | $3.5M | $134.0M | $2.6M | $75.2M | ||
| Purchases Of Portfolio Investments | $287.7M | $446.1M | $104.1M | $66.5M | ||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -$5.0M | -$651.0K | $2.7M | $3.8M | ||||||||||
| Accretion Amortization Of Discounts And Premiums Investments | $3.5M | $2.6M | $2.1M | $750.0K | ||||||||||
| Retained Earnings Accumulated Deficit | $6.7M | $10.0M | $20.4M | $33.1M | $24.0M | $21.3M | $12.2M | $20.3M | $20.0M | $25.8M | ||||
| Prepaid Expense And Other Assets | $346.0K | $239.0K | $290.0K | $161.0K | $117.0K | $266.0K | $119.0K | $207.0K | $283.0K | $157.0K | ||||
| Management Fee Payable | $5.6M | $4.6M | $3.8M | $3.6M | $3.8M | $3.5M | $2.9M | $2.8M | $2.7M | $1.9M | ||||
| Liabilities And Stockholders Equity | $2.34B | $2.26B | $2.23B | $2.03B | $1.91B | $1.84B | $1.32B | $1.32B | $1.29B | $992.4M | ||||
| Liabilities | $1.20B | $1.10B | $1.05B | $842.0M | $731.7M | $1.03B | $639.9M | $677.7M | $699.3M | $468.7M | ||||
| Interest Receivable | $21.5M | $21.3M | $17.2M | $22.4M | $16.8M | $15.6M | $13.7M | $12.3M | $13.6M | $8.0M | ||||
| Common Stock Value | $70.0K | $71.0K | $71.0K | $71.0K | $71.0K | $49.0K | $42.0K | $39.0K | $36.0K | $31.0K | ||||
| Assets | $2.34B | $2.26B | $2.23B | $2.03B | $1.91B | $1.84B | $1.32B | $1.32B | $1.29B | $992.4M | ||||
| Accrued Liabilities And Other Liabilities | $18.0M | $18.6M | $13.9M | $13.2M | $14.6M | $10.9M | $10.6M | $9.7M | $6.6M | $4.6M | ||||
| Paidinkind Interest From Portfolio Investments | $306.0K | $284.0K | $165.0K | |||||||||||
| Increasedecrease In Receivable For Principal Payments On Investments | -$320.0K | $189.0K | $79.0K | |||||||||||
| Receivable For Principal Payments On Investments | $334.0K | $615.0K | $220.0K | $501.0K | $5.3M | $293.0K | $179.0K | $148.0K | $190.0K | $273.0K | ||||
| Net Increase In Net Assets Resulting From Capital Share Transactions | $363.9M | $120.3M | $41.9M | $51.1M | $955.0K | $126.4M | $1.2M | $69.5M | $45.6M | |||||
| Net Change In Unrealized Gains Losses Investments | -$3.1M | $4.0M | -$7.5M | -$731.0K | $125.0K | $3.3M | $322.0K | -$512.0K | $989.0K | |||||
| Distribution Payable | $27.9M | $28.3M | $28.5M | $28.4M | $28.4M | $19.5M | $22.0M | $20.7M | ||||||
| Shortterm Investmentsamortized Cost | $22.7M | $20.3M | $10.9M | $16.6M | $15.1M | $15.2M | $4.8M | |||||||
| Short Term Investments | $22.7M | $20.3M | $10.9M | $16.6M | $15.1M | $15.2M | $4.8M | |||||||
| Gain Loss On Investments | -$5.0M | -$3.5M | -$5.9M | $503.0K | -$3.2M | $4.0M | -$7.5M | |||||||
| Cash And Cash Equivalents At Carrying Value | $39.1M | $20.3M | $33.4M | $12.4M | $12.9M | $11.2M | $15.3M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Proceeds From Sales Of Investments And Principal Repayments | $569.9M | $370.4M | $196.6M | $142.1M | $82.5M |
| Payments Of Debt Issuance Costs | $6.8M | $7.2M | $3.7M | $6.9M | $932.0K |
| Net Cash Provided By Used In Operating Activities | -$98.7M | -$544.5M | -$110.1M | -$541.8M | -$559.1M |
| Net Cash Provided By Used In Financing Activities | $94.4M | $532.8M | $135.6M | $548.3M | $561.2M |
| Increase Decrease In Interest And Dividends Receivable | $6.4M | $2.1M | $2.4M | $8.3M | $2.1M |
| Payments Of Capital Distribution | $101.8M | $70.0M | $23.1M | $4.4M | |
| Proceeds From Issuance Of Common Stock | $481.0M | $90.6M | $268.2M | $299.5M | |
| Increase Decrease In Prepaid Expenses Other | $639.0K | -$28.0K | $199.0K | -$29.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 |
|---|---|---|---|---|
| Proceeds From Sales Of Investments And Principal Repayments | $114.0M | $32.4M | $17.2M | $28.2M |
| Payments Of Debt Issuance Costs | $3.5M | $105.0K | $67.0K | $4.9M |
| Net Cash Provided By Used In Operating Activities | -$127.2M | -$91.0M | -$76.9M | -$31.2M |
| Net Cash Provided By Used In Financing Activities | $122.2M | $90.4M | $79.6M | $34.9M |
| Increase Decrease In Interest And Dividends Receivable | $2.3M | $2.7M | $3.2M | $1.0M |
| Payments Of Capital Distribution | $20.5M | $14.5M | $3.7M | |
| Proceeds From Issuance Of Common Stock | $118.7M | $68.6M | ||
| Increase Decrease In Prepaid Expenses Other | -$53.0K | -$64.0K | $38.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Net Asset Value Per Share | $16.32 | $16.70 | $16.42 | $16.50 | $16.22 | $14.86 |
| Weighted Average Number Of Shares Outstanding Basic | 70.3M | 63.8M | 39.3M | 27.2M | 10.7M | |
| Weighted Average Number Of Diluted Shares Outstanding | 70.3M | 63.8M | 39.3M | 27.2M | 10.7M | |
| Earnings Per Share Diluted | $1.67 | $2.03 | $2.16 | $1.48 | $0.94 | |
| Earnings Per Share Basic | $1.67 | $2.03 | $2.16 | $1.48 | $0.94 | |
| Common Stock Shares Outstanding | 68.0M | 71.1M | 41.6M | 35.9M | 19.2M | |
| Common Stock Shares Issued | 68.0M | 71.1M | 41.6M | 35.9M | 19.2M | |
| Common Stock Shares Authorized | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Asset Value Per Share | $16.34 | $16.37 | $16.51 | $16.70 | $16.57 | $16.63 | $16.40 | $16.58 | $16.57 | $16.73 | $16.55 | ||
| Weighted Average Number Of Shares Outstanding Basic | 70.4M | 70.9M | 71.2M | 71.1M | 67.4M | 45.3M | 40.5M | 38.9M | 35.9M | 29.5M | 23.5M | 22.4M | 11.4M |
| Weighted Average Number Of Diluted Shares Outstanding | 70.4M | 70.9M | 71.2M | 71.1M | 67.4M | 45.3M | 40.5M | 38.9M | 35.9M | 29.5M | 23.5M | 22.4M | 11.4M |
| Earnings Per Share Diluted | $0.43 | $0.40 | $0.40 | $0.52 | $0.51 | $0.52 | $0.53 | $0.56 | $0.54 | $0.38 | $0.30 | $0.28 | |
| Earnings Per Share Basic | $0.43 | $0.40 | $0.40 | $0.52 | $0.51 | $0.52 | $0.53 | $0.56 | $0.54 | $0.38 | $0.30 | $0.28 | |
| Common Stock Shares Outstanding | 69.8M | 70.7M | 71.3M | 71.0M | 71.1M | 48.8M | 41.5M | 39.0M | 35.9M | 31.3M | |||
| Common Stock Shares Issued | 69.8M | 70.7M | 71.3M | 71.0M | 71.1M | 48.8M | 41.5M | 39.0M | 35.9M | 31.3M | |||
| Common Stock Shares Authorized | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | |||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Professional Fees | $1.4M | $1.5M | $691.0K | $645.0K | $597.0K |
| Noninterest Expense Directors Fees | $638.0K | $621.0K | $611.0K | $460.0K | $307.0K |
| Net Investment Income | $117.6M | $129.3M | $84.8M | $40.2M | $10.1M |
| Management Fee Expense | $21.7M | $17.5M | $11.4M | $7.1M | $2.1M |
| Amortization Of Financing Costs | $4.0M | $3.7M | $2.7M | $2.1M | $260.0K |
| Stock Issued During Period Value Dividend Reinvestment Plan | $4.0M | $3.8M | $5.0M | $5.6M | $1.5M |
| Incentive Fee Expense | $17.3M | $17.4M | $9.4M | $4.7M | $65.0K |
| Stock Issued During Period Value New Issues | $481.0M | $90.6M | $268.2M | $299.5M | |
| Noncash Financing Activities Not Included Herein Consisted Of Reinvestment Of Dividends | $4.0M | $3.8M | $5.0M | $5.6M | $1.5M |
| Interest Paid Net | $67.5M | $55.0M | $44.4M | $14.2M | $2.3M |
| Realized Investment Gains Losses | -$79.0K | $570.0K | -$10.7M | $84.0K | $332.0K |
| Borrowings On Revolving Funding Facility Net | $105.0M | $114.0M | $106.0M | $200.0M | |
| Borrowings On Subscription And Credit Agreement Net | -$10.8M | -$97.3M | $3.0M | $105.0M | |
| Unamortized Revolving Funding Facility Issuance Costs | -$4.7M | -$4.7M | -$2.0M | -$2.8M | |
| Revolving Funding Facility Note | $525.0M | $420.0M | $306.0M | $200.0M | |
| Line Of Credit | $135.0M | $250.0M | $234.0M | $269.0M | |
| Net Realized And Unrealized Gainloss On Investment | -$7.7M | $5.6M | $12.2M | ||
| Investment Income Interest | $160.4M | $74.8M | $18.8M | ||
| Unamortized Subscription Credit Facility Issuance Costs | -$3.4M | -$3.2M | -$41.0K | -$65.0K | -$425.0K |
| Investment Company Distribution To Shareholders | $81.6M | $39.6M | $10.5M | ||
| Borrowingspayments On Corporate Credit Facility Net | $115.0M | -$16.0M | $35.0M | -$269.0M | |
| Investment Income Dividend | $1.1M | $1.5M | $571.0K | ||
| Investment Company Increase Decrease From Share Transaction | -$44.0M | $483.3M | $95.6M | $273.9M | |
| Investment Company Dividend Distribution | $126.2M | $111.9M | $81.6M | $39.6M | |
| Unamortized Notes Issuance Costs | -$2.6M | -$643.0K | -$851.0K | ||
| Senior Unsecured Notes | $274.7M | $75.0M | $75.0M | ||
| Investment Company Net Asset From Operations Increase Decrease | $77.1M | $45.8M | $22.3M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Professional Fees | $369.0K | $368.0K | $345.0K | $403.0K | $375.0K | $264.0K | $189.0K | $143.0K | $150.0K | $166.0K | $155.0K | $145.0K | $140.0K |
| Noninterest Expense Directors Fees | $158.0K | $158.0K | $158.0K | $158.0K | $158.0K | $147.0K | $147.0K | $178.0K | $139.0K | $107.0K | $107.0K | $107.0K | $81.0K |
| Net Investment Income | $30.0M | $28.7M | $28.7M | $37.1M | $34.4M | $23.8M | $21.4M | $21.7M | $19.3M | $11.2M | $7.1M | $6.2M | $3.0M |
| Management Fee Expense | $5.6M | $5.4M | $5.1M | $4.8M | $4.3M | $3.5M | $2.9M | $2.8M | $2.7M | $1.9M | $1.5M | $1.3M | $545.0K |
| Amortization Of Financing Costs | $980.0K | $934.0K | $921.0K | $947.0K | $927.0K | $897.0K | $752.0K | $593.0K | $591.0K | $528.0K | $486.0K | $519.0K | $55.0K |
| Stock Issued During Period Value Dividend Reinvestment Plan | $4.0M | $1.6M | $3.2M | $1.4M | $1.1M | $2.0M | $1.4M | $1.2M | $902.0K | $585.0K | |||
| Incentive Fee Expense | $4.4M | $4.5M | $4.5M | $5.6M | $4.1M | $2.6M | $2.4M | $2.4M | $2.1M | $1.2M | $775.0K | $955.0K | |
| Stock Issued During Period Value New Issues | $362.3M | $118.7M | $40.6M | $50.0M | $125.0M | $68.6M | $45.0M | ||||||
| Noncash Financing Activities Not Included Herein Consisted Of Reinvestment Of Dividends | $4.0M | $1.6M | $955.0K | $902.0K | |||||||||
| Interest Paid Net | $17.8M | $15.8M | $11.2M | $1.6M | |||||||||
| Realized Investment Gains Losses | -$22.0K | -$10.0K | $566.0K | -$138.0K | $47.0K | $28.0K | $131.0K | ||||||
| Borrowings On Revolving Funding Facility Net | $157.0M | $13.0M | $75.0M | $150.0M | |||||||||
| Borrowings On Subscription And Credit Agreement Net | -$10.8M | -$16.0M | -$91.0M | ||||||||||
| Unamortized Revolving Funding Facility Issuance Costs | -$5.2M | -$5.8M | -$6.3M | -$5.3M | -$5.8M | -$1.6M | -$2.4M | -$2.9M | -$2.5M | -$2.2M | |||
| Revolving Funding Facility Note | $570.0M | $574.0M | $577.0M | $409.0M | $389.0M | $319.0M | $306.0M | $320.0M | $275.0M | $200.0M | |||
| Line Of Credit | $301.0M | $224.0M | $194.0M | $221.0M | $75.0M | $198.0M | $192.0M | $237.0M | $297.0M | $202.0M | |||
| Net Realized And Unrealized Gainloss On Investment | -$3.2M | $4.0M | -$7.5M | -$731.0K | $125.0K | $3.4M | $322.0K | -$484.0K | $1.1M | ||||
| Investment Income Interest | $52.0M | $46.2M | $41.0M | $40.7M | $36.4M | $20.5M | $13.0M | $11.9M | $5.0M | ||||
| Unamortized Subscription Credit Facility Issuance Costs | -$3.6M | -$2.8M | -$3.0M | -$37.0K | -$63.0K | -$65.0K | -$113.0K | ||||||
| Investment Company Distribution To Shareholders | $28.4M | $19.5M | $22.0M | $20.7M | $16.9M | $7.1M | $6.1M | $2.0M | |||||
| Borrowingspayments On Corporate Credit Facility Net | $56.0M | $36.0M | -$28.0M | ||||||||||
| Investment Income Dividend | $412.0K | $178.0K | $231.0K | $278.0K | $462.0K | $257.0K | $156.0K | ||||||
| Investment Company Increase Decrease From Share Transaction | -$13.9M | -$8.8M | $3.6M | -$1.1M | $363.9M | $120.3M | $41.9M | ||||||
| Investment Company Dividend Distribution | $27.9M | $35.4M | $35.6M | $28.4M | $28.4M | $19.5M | $22.0M | ||||||
| Unamortized Notes Issuance Costs | -$639.0K | -$541.0K | -$593.0K | -$696.0K | -$748.0K | -$799.0K | -$903.0K | -$881.0K | |||||
| Senior Unsecured Notes | $75.0M | $75.0M | $75.0M | $75.0M | $75.0M | $75.0M | $75.0M | $75.0M | |||||
| Investment Company Net Asset From Operations Increase Decrease | $31.2M | $27.8M | $13.9M | $21.0M | $19.4M | $14.6M | $7.5M | $5.7M |
Most recent annual filing with the SEC: March 2, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.